Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

Allergan, Inc.

(“Allergan” or the “Company”) today filed an answer in the United States District Court for the Central District of California responding to Valeant Pharmaceuticals International, Inc. (“Valeant”) and Pershing Square Capital Management, L.P.'s (“Pershing Square”) counterclaims regarding Allergan's statements on the unsustainability of Valeant's underlying business model. The federal court case is Allergan, Inc. v. Valeant Pharmaceuticals International, Inc., No. 14-CV-1214-DOC (ANx) (C.D. Cal.).